Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424500 · ClinicalTrials.gov registry record · NA
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
A NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, sponsored by Hygieia Research.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
- 1
- Study location
NCT02424500 is a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia that has completed, run by Hygieia Research. The registered enrollment target is 181 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02424500, a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, has completed, sponsored by Hygieia Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
- 1
- Study location
Study Summary
Hygieia Research seeks to conduct a prospective randomized clinical study involving adult subjects with uncontrolled Type-2 diabetes requiring insulin. The study seeks to demonstrate that the clinical application of the d-Nav will achieve metabolic control in a safe and effective manner.
Conditions Studied
Interventions
- DEVICE d-Nav
- DEVICE Blood Glucose Monitoring System
Study Locations (1)
Minnesota
- Park Nicollet Institute / International Diabetes Center, Minneapolis, MN - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02424500
The ClinicalTrials.gov registry entry for NCT02424500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The listed sponsor is Hygieia Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which d-Nav is the first listed.
NCT02424500 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02424500 about?
NCT02424500 is a clinical study titled "Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy". Hygieia Research seeks to conduct a prospective randomized clinical study involving adult subjects with uncontrolled Type-2 diabetes requiring insulin. The study seeks to demonstrate that the clinical application of the d-Nav will achieve metabolic control in a safe and effective manner.
What is the current status of trial NCT02424500?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2015-01. Estimated completion is 2017-06-30.
What conditions does trial NCT02424500 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Hypoglycemia.
What interventions are being tested in trial NCT02424500?
The interventions under investigation include: d-Nav (DEVICE), Blood Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT02424500?
This trial is sponsored by Hygieia Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02424500 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.